BioCardia, Inc. SEC filings BCDA

BioCardia, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Sep 27, 2007. Its latest annual report, Form 10-K, was filed on Mar 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.

BioCardia, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 20, 2026 Oct 15, 2026
8-K Current report
Other events
Oct 19, 2026 Oct 19, 2026
8-K Current report
Other events
Oct 7, 2026 Oct 7, 2026
8-K Current report
Other events
Oct 1, 2026 Oct 1, 2026
4 Insider transaction Sep 30, 2026 Sep 29, 2026
4 Insider transaction Sep 23, 2026 Sep 23, 2026
8-K Current report
Other events
Sep 23, 2026 Sep 23, 2026
8-K Current report
Other events
Sep 21, 2026 Sep 21, 2026
8-K Current report
Other events
Sep 10, 2026 Sep 10, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
8-K Current report
Regulation FD disclosure
Aug 24, 2026 Aug 24, 2026
8-K Current report
Listing notice
Aug 21, 2026 Aug 19, 2026
4 Insider transaction Aug 18, 2026 Aug 17, 2026
4 Insider transaction Aug 13, 2026 Aug 13, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
4 Insider transaction Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 20, 2026 Jul 17, 2026
4 Insider transaction Jul 15, 2026 Jul 14, 2026
4 Insider transaction Jul 10, 2026 Jul 8, 2026
4 Insider transaction Jul 8, 2026 Jul 8, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
8-K Current report
Regulation FD disclosure
Jun 18, 2026 Jun 18, 2026
8-K Current report
Listing notice
Jun 12, 2026 Jun 12, 2026
4 Insider transaction Jun 9, 2026 Jun 9, 2026
8-K Current report
Other events
Jun 8, 2026 Jun 8, 2026
8-K Current report
Regulation FD disclosure
Jun 5, 2026 Jun 5, 2026
8-K Current report
Regulation FD disclosure
May 28, 2026 May 28, 2026
4 Insider transaction May 21, 2026 May 19, 2026
8-K Current report
Regulation FD disclosure
May 21, 2026 May 21, 2026
4 Insider transaction May 18, 2026 May 18, 2026
4 Insider transaction May 15, 2026 May 15, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 8, 2026 May 8, 2026
4 Insider transaction Apr 29, 2026 Apr 29, 2026
8-K Current report
Other events
Apr 28, 2026 Apr 28, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
8-K Current report
Regulation FD disclosure
Apr 20, 2026 Apr 20, 2026
8-K Current report
Listing notice
Apr 15, 2026 Apr 10, 2026
8-K Current report
Regulation FD disclosure
Apr 2, 2026 Apr 2, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
8-K Current report
Results of operations
Mar 24, 2026 Mar 24, 2026
S-8 Employee stock plan registration Mar 24, 2026 —
10-K Annual report Mar 24, 2026 Dec 31, 2025
8-K Current report
Other events
Mar 17, 2026 Mar 17, 2026
8-K Current report
Regulation FD disclosure
Mar 3, 2026 Mar 3, 2026
8-K Current report
Other events
Feb 10, 2026 Feb 10, 2026
4 Insider transaction Feb 4, 2026 Feb 4, 2026
8-K Current report
Other events
Feb 3, 2026 Feb 3, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
S-8 Employee stock plan registration Dec 18, 2025 —
4 Insider transaction Dec 17, 2025 Dec 16, 2025
8-K Current report
Regulation FD disclosure
Dec 16, 2025 Dec 16, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
3 Initial insider ownership Dec 10, 2025 Dec 2, 2025
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Dec 3, 2025 Dec 2, 2025
8-K Current report
Other events
Nov 24, 2025 Nov 24, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Other events
Nov 10, 2025 Nov 10, 2025
DEF 14A Proxy statement Nov 3, 2025 Dec 2, 2025
8-K Current report
Other events
Oct 30, 2025 Oct 30, 2025
10-Q/A Amended quarterly report Oct 29, 2025 Jun 30, 2025
424B5 Prospectus supplement Oct 24, 2025 —
8-K Current report Oct 7, 2025 Oct 7, 2025
8-K Current report
Other events
Oct 2, 2025 Oct 2, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 24, 2025 —
8-K Current report
Listing notice
Sep 24, 2025 Sep 24, 2025
4 Insider transaction Sep 23, 2025 Sep 19, 2025
4 Insider transaction Sep 23, 2025 Sep 19, 2025
4 Insider transaction Sep 23, 2025 Sep 19, 2025
8-K Current report
Other events
Sep 22, 2025 Sep 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 19, 2025 —
8-K Current report
Other events
Sep 19, 2025 Sep 19, 2025
424B4 Prospectus Sep 19, 2025 —
EFFECT Filing Sep 18, 2025 —
8-K Current report
Regulation FD disclosure
Sep 18, 2025 Sep 18, 2025
8-K Current report
Regulation FD disclosure
Sep 18, 2025 Sep 18, 2025
CORRESP Letter to the SEC Sep 17, 2025 —
S-1/A Amended registration statement Sep 17, 2025 —
CORRESP Letter to the SEC Sep 16, 2025 —
S-1 Registration statement Sep 16, 2025 —
4 Insider transaction Aug 25, 2025 Aug 22, 2025
4 Insider transaction Aug 13, 2025 Aug 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 11, 2025 Aug 11, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Other events
Aug 4, 2025 Aug 4, 2025
8-K Current report
Other events
Jul 24, 2025 Jul 24, 2025
EFFECT Filing Jul 17, 2025 —
EFFECT Filing Jul 17, 2025 —
8-K Current report
Other events
Jul 16, 2025 Jul 16, 2025
CORRESP Letter to the SEC Jul 15, 2025 —
CORRESP Letter to the SEC Jul 15, 2025 —
UPLOAD Letter from the SEC Jul 14, 2025 —
S-3 Shelf registration Jul 9, 2025 —
424B5 Prospectus supplement Jul 8, 2025 —
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
8-K Current report
Unregistered share sale, Other events
Jul 2, 2025 Jun 30, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
4 Insider transaction May 30, 2025 May 30, 2025
4 Insider transaction May 22, 2025 May 20, 2025
SCHEDULE 13D Ownership over 5% (active) May 22, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 21, 2025 —
4 Insider transaction May 16, 2025 May 14, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Other events
May 6, 2025 May 6, 2025
UPLOAD Letter from the SEC May 5, 2025 —
8-K Current report
Regulation FD disclosure
May 1, 2025 Apr 30, 2025
S-3 Shelf registration Apr 30, 2025 —
4 Insider transaction Apr 28, 2025 Apr 23, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
8-K Current report
Unregistered share sale, Other events
Apr 23, 2025 Apr 22, 2025
4 Insider transaction Apr 17, 2025 Apr 15, 2025
8-K Current report
Regulation FD disclosure
Apr 15, 2025 Apr 15, 2025
4 Insider transaction Apr 14, 2025 Apr 10, 2025
8-K Current report
Other events
Apr 11, 2025 Apr 11, 2025
4 Insider transaction Apr 8, 2025 Apr 7, 2025
4 Insider transaction Apr 7, 2025 Apr 4, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
424B5 Prospectus supplement Apr 4, 2025 —
8-K Current report
Listing notice
Apr 4, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 3, 2025
8-K Current report
Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 31, 2025 Mar 31, 2025
S-8 Employee stock plan registration Mar 26, 2025 —
8-K Current report
Results of operations
Mar 26, 2025 Mar 26, 2025
10-K Annual report Mar 26, 2025 Dec 31, 2024
UPLOAD Letter from the SEC Mar 20, 2025 —
DRS Filing Mar 17, 2025 —
8-K Current report
Other events
Mar 10, 2025 Mar 10, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
8-K Current report
Other events
Feb 27, 2025 Feb 27, 2025
8-K Current report
Other events
Feb 13, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Jan 30, 2025 Jan 29, 2025
8-K Current report
Other events
Jan 27, 2025 Jan 27, 2025
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 20, 2024
144 Notice of proposed sale Dec 17, 2024 —
8-K Current report
Other events
Dec 17, 2024 Dec 17, 2024
4 Insider transaction Dec 9, 2024 Dec 5, 2024
8-K Current report
Other events
Dec 4, 2024 Dec 4, 2024
424B5 Prospectus supplement Dec 2, 2024 —
4 Insider transaction Nov 19, 2024 Nov 15, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Other events
Oct 28, 2024 Oct 28, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
4 Insider transaction Oct 16, 2024 Oct 11, 2024
8-K Current report
Other events
Sep 18, 2024 Sep 18, 2024
8-K Current report
Other events
Sep 9, 2024 Sep 3, 2024
SC 13G Ownership over 5% (passive) Sep 6, 2024 —
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BCDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Sunnyvale, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
925741
Former names
Tiger X Medical, Inc. (until Oct 17, 2016); Cardo Medical, Inc. (until May 25, 2011); CLICKNSETTLE COM INC (until Oct 20, 2008); NAM CORP (until Mar 29, 2000)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.